Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. DexCom Inc (DXCM)

  7. DexCom Inc (DXCM) Financials

DXCM

DexCom Inc
113.815
0.00 (0.0%)
Upgrade to Real-Time

DexCom Inc. (DXCM) Fundamentals
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem.
SHARE INFORMATION
Market Cap$ 43,979,674,127
Shares Outstanding386,413,690
Float343,205,018
Percent Float88.82%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 2,909,800,000
Latest Fiscal EPS$ 0.81
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions1,954
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months33,049,529
Institutional Holdings Percent180.3%
Institutional Sold Previous 3 Months71,748,901
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months90,720
Insider Holdings Percent0.6
Insider Sold Previous 3 Months127,288
Insider Shares Owned2,155,075
TRADING INFO
52 Week High$ 134.77
52 Week Low$ 66.89
52 Week High Change$ -8.04
21 Day Moving Average$ 114.3464
21 Day Extended Moving Average$ 114.2219
50 Day Moving Average$ 111.9289
50 Day Extended Moving Average$ 112.9496
200 Day Moving Average$ 99.7409
200 Day Extended Moving Average$ 106.7569
10 Day Average Volume1,829,450
20 Day Average Volume2,346,312
30 Day Average Volume2,335,226
50 Day Average Volume2,464,628
Alpha0.037473
Beta1.0940
Standard Deviation0.157305
R20.140266
7 Day Price Change$ -5.17
7 Day Percent Change-4.34%
21 Day Price Change$ 0.005
21 Day Percent Change0.0%
30 Day Price Change$ 2.81
30 Day Percent Change2.53%
Month to Date Price Change$ 2.81
Month to Date Percent Change2.53%
Quarter to Date Price Change$ 0.57501
Quarter to Date Percent Change0.51%
180 Day Price Change$ 30.49
180 Day Percent Change36.58%
200 Day Price Change$ 20.93
200 Day Percent Change22.53%
Year to Date Price Change$ 0.57501
Year to Date Percent Change0.51%

DexCom Inc. (DXCM) Key Ratios

PROFITABILITY
EBIT Margin10.1%
EBITDA Margin15.5%
Pre-Tax Profit Margin4.1%
Profit Margin Count11.7%
Gross Margin64.7%
Profit Margin TOT11.7%
INCOME STATEMENTS
Revenue$ 2,909,800,000
Revenue Per Share$ 7.5303
Revenue (3 Years)$ 25.56
Revenue (5 Years)$ 32.51
FINANCIAL STRENGTH
Price to Tangible Book22.80
Total Debt To Equity1.00
Int Coverage22.00
Current Ratio2.00
Leverage Ratio2.50
Quick Ratio1.70
Long Term Debt To Capital0.39
VALUATION MEASURES
PE Ratio139.10
Enterprise Value$ 43,774,737,892
Price to Sales15.1143
Price to Free Cash146.60
PE High Last 5 Years418.60
Price To Book20.70
Price To Cash Flow72.90
PE Low Last 5 Years-86.50
Price to Tangible Book22.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover4.50
Invoice Turnover2.70
Assets Turnover0.60
Return Assets6.79
Return on Equity16.82
Return on Capital6.08

DexCom Inc. (DXCM) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOKevin R. Sayer
Emplyoees7600
Last AuditUQ
CIK0001093557
IndustryMedical Devices & Instruments
SectorHealthcare
NAICSIn-Vitro Diagnostic Substance Manufacturing(325413)
CONTACT INFO
Address6340 Sequence Drive
San Diego, CA 92121
Websitehttps://www.dexcom.com
Facsimile-
Telephone+1 858 200-0200
Emailinvestorrelations@dexcom.com


Your Recent History
NASDAQ
DXCM
DexCom
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.